We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Philips, N-of-One Team Up On Cancer Genomics
News

Philips, N-of-One Team Up On Cancer Genomics

Philips, N-of-One Team Up On Cancer Genomics
News

Philips, N-of-One Team Up On Cancer Genomics

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Philips, N-of-One Team Up On Cancer Genomics"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Royal Philips and N-of-One, Inc. announced they are teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips new precision medicine solution for oncology. This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with precision diagnostics and therapeutics, to enable them to measure the success of precision healthcare programs.

Profiling tumors using genomic information is critical for complex cancer cases, yet challenges remain in rapidly and accurately interpreting genomic findings in the context of a patient’s condition. While most cancer patients have thousands of gene variants and mutations, only a small number drive the individual’s specific cancer or may have actionable therapeutic implications for a particular patient.

The Philips IntelliSpace Genomics solution, which uniquely integrates complete patient information, is coupled with N-of-One’s rich experience and extensive knowledge-bases. For the first time, clinicians will have full access to N-of-One’s variant database during the case filtering and interpretation process, providing them ready access to the vast amount of available reference literature, guidelines, and evidence, in a fully interactive framework. The aim is to help clinicians determine which treatment options, clinical trials or medications, are best suited to a specific case.

Story from N-of-One. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.

Advertisement